Ultrasound in Evaluation of Preoperative Fluid Management of Hip Fracture Surgery Patients

Hip Fractures Clinical Trial

Official title:

Evaluation of Ultrasound on Peroperative Fluid Management in Patients Undergoing Hip Surgery Under Spinal Anesthesia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05916599
• Other study ID #: 138
• Status: Recruiting
• Start date: January 3, 2023
• Est. completion date: September 12, 2023

Study information

• Verified date: June 2023
• Source: Gaziosmanpasa Research and Education Hospital
• Contact: zuhal Çavus, MD
• Phone: 05326323166
• Email: zuhalcavus74[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Goal directed fluid therapy is a new standard surgical procedure which is successful in patients undergoing hip revision arthroplasty, There has been a reduction of postoperative complications, most importantly surgery with a decrease inbleeding, as well as in hospital and intensive care stays it is related. The aim of this study is to evaluate effectiveness of pulmonary ultrasound score and vena cava collapse index measurements in the patients undergoing hip surgery under spinal anesthesia and relation with peroperative fluid management.

Description:

Patients who will undergo hip surgery under spinal anesthesia using the closed envelope method it will be randomized and divided into 2 groups.

1.The inferior vena cava collapse index IVC CI and lung ultrasound score (LUS) measurements and goal directed fluid therapy will be done 2. Group applying zero balance liquid therapy to patients with conventional methods is planned.

1. Patients in the group will be started with fluid replasment at an hourly rate of 2ml/kg/h and with ultrasound measurement the infused fluid will be evaluated and regulated.

2. Crystalloid liquid infusion at a rate of 2ml/kg/hour will be administered to the patients in the group additional fluid replacement will be decided by monitoring bleeding and urinary output, zero balance is aimed at patients. Both groups were treated with spinal anesthesia in the postoperative period 120. minute IVC CI and the LUS score value will be checked.

If the CI is below 50% and the LUS score is below 15, fluid management will be considered as successful.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 70
• Est. completion date: September 12, 2023
• Est. primary completion date: August 9, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 65 Years to 110 Years

Eligibility

Inclusion Criteria:

• Patients over the age of 65 who will undergo hip surgery

• ASA I-II-III patients

Exclusion Criteria:

• Patients under the age of 65

• Patients with ASA IV-V

• Patients with BMI>above 35

• Patients with an Lus score of 15 and above

• Patients who have not undergone spinal anesthesia

Related Conditions & MeSH terms

• Hip Fractures
• Lung Edema

Intervention

Device:
• ultrasound
a device which is used in intensive care units,

Locations

Country	Name	City	State
Turkey	Gaziosmanpasa Education and Research Hospital	Istanbul	Gaziosmanpasa

Sponsors (1)

Lead Sponsor	Collaborator
Gaziosmanpasa Research and Education Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	comparison of groups for change of vena cava inferior collapsibility index in 4 time frames	vena cava inferior collapsibility index will be measured at 4 time frames by using ultrasound,changes over 20% will be considered as significant	vena cava inferior collapsibility index measurements will be done in 4 time frames.1.just before spinal anesthesia, 2. at fifth minute of surgery ,3. at 15. minute of surgery, 4 immediatelyafter surgery
Secondary	comparison of groups for pulmonary edema	detecting 12 parts of lung with ultrasound with a score of 1-36	measurements will be done in 4 time frames.1.just before spinal anesthesia, 2. at fifth minute of surgery ,3. at 15. minute of surgery, 4immediately after surgery